Post Categories
Experts Assess Risk of Avian Flu to Humans
July 29, 2024
United States agricultural hubs are currently facing an unprecedented outbreak of the H5N1 virus, more commonly known as the avian flu or “bird flu.”…
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making…
Could an Exercise Pill Mimic the Benefits of an Active Lifestyle?
July 17, 2024
Regular exercise is a crucial element in maintaining lifelong health. Exercise promotes bone health, counteracts poor mood, and reduces the risk of chronic, life-threatening…
Taking the Javan Tiger by a Hair: DNA Evidence Suggests the Species Is Not Extinct
July 15, 2024
In the summer of 2019, Ripi Yanuar Fajar and his friends had a startling and memorable encounter. In Sukabumi, West Java, Indonesia, they came…
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with…
Cheating & Cooperating: How Viruses Communicate
June 19, 2024
Since their discovery in the late 1800s, viruses have been considered simple organisms largely incapable of communication. But today’s virologists have changed their tune;…
RNA Editing: A Safer Alternative in Genetic Medicine?
June 17, 2024
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated…
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
June 10, 2024
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to…
Understanding the Rise in Cancer Rates Among Young Adults
May 13, 2024
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the…
Less Sitting, More Living: How Activity Reduces Risk for Heart Attack Survivors
June 24, 2025
Sitting down might seem harmless, but for heart attack survivors, prolonged sedentary time could spell significant trouble. According to recent research, replacing just 30…
Sight Concerns: Investigating the Link Between GLP-1 RA Medications and Eye Health
June 16, 2025
Glucagon-like peptide (GLP-1) receptor agonists (GLP-1 RAs) are transformative medications for millions of people managing diabetes and obesity. Amid research demonstrating the many benefits…
Non-Opioid Painkiller Blocks Pain at Its Source
June 11, 2025
Synthetic and semi-synthetic opioids offer powerful pain relief. Unfortunately, these drugs are also associated with negative outcomes, including addiction and overdose. The U.S. Centers…
Injecting Hope: Early Steps Toward Prenatal Treatment for Genetic Disorders
June 9, 2025
The potential to treat severe genetic disorders before birth has taken a promising step forward. Researchers at the University of California, San Francisco (UCSF)…
Unanswered Questions: Mysterious Cluster of Brain Tumors Investigated at Massachusetts Hospital
June 2, 2025
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital in Massachusetts have been diagnosed with benign brain tumors, sparking concern about a…
Creutzfeldt-Jakob Disease Outbreak Sparks Concern
May 21, 2025
Prion diseases are rapidly progressive, neurodegenerative disorders caused by infectious protein particles called prions. While these diseases can affect both humans and animals, they…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…